Alexey S. Chiriapkin

Alexey S. Chiriapkin

Auto-generated profile, based on publicly available information

Alexey S. Chiriapkin

Пятигорский медико-­фармацевтический институт — филиал ВолгГМУ

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2023 in Juvenis scientia
Verified
Journal Article
Open access
PDF file
ACA. S. Chiriapkin
A. S. Chiriapkin
DZD. S. Zolotykh
D. S. Zolotykh
DPDmitry Pozdnyakov
Dmitry Pozdnyakov
Flavonoids are an extensive class of secondary metabolites present in varying concentrations in different parts of plants. Medicinal raw materials containing flavonoids have been used in traditional medicine in various countries for centuries and are also used in modern medicine for the production of drugs. Compared to other groups of secondary metabolites, flavonoids are often present in relatively large amounts. Interest in flavonoids is driven by constantly updated data on their biological activity and their wide distribution in the plant world. This review focuses on the two most commonly occurring polyphenolic compounds in plants, quercetin and kaempferol. The article describes the main glycosidic forms of the flavonoids under consideration and the modern results of studying their biological activity, namely their antioxidant, anti-allergic, anti-inflammatory, cardioprotective, and anti-tumor properties. In addition, some of the mechanisms for implementing the above types of biological activity are discussed. The analysis suggests that further in-depth pharmacological research on these flavonoids and the development of new advanced drugs based on them is promising. The cores of quercetin and kaempferol can be recommended for chemical modification to obtain highly active compounds with antioxidant, anti-allergic, anti-inflammatory, cardioprotective, and anti-tumor activities. Keywords: flavonoids, quercetin, kaempferol, glycosidic forms, biological activity, antioxidant activity, anti-allergic activity, anti-inflammatory activity, cardioprotective activity, anti-tumor activity, mechanisms of action, drugs, chemical modification.

13 May 2022 in Iranian Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
ACAlexey Chiriapkin
Alexey Chiriapkin
IKIvan Kodonidi
Ivan Kodonidi
DPDmitry Pozdnyakov
Dmitry Pozdnyakov
Background: The high prevalence of skin hyperpigmentation makes it necessary to search for remedies that could hinder this process. Among such substances, tyrosinase inhibitors can be distinguished, which may be pyrimidine derivatives. Objectives: This study aimed to investigate new compounds with anti-tyrosinase activity in 2-substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one by an in vitro analysis and investigating their molecular docking. Methods: A molecular docking was performed using AutoDock 4.0 with the 3-dimensional structure of tyrosinase of the fungus Agaricus bisporus from the Protein Data Bank (PDB; rcsb.org) with identification number 2Y9X. A synthesis of 2-substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one was carried out during the heterocyclization reaction of azomethine derivatives of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide in glacial acetic acid with the addition of dimethyl sulfoxide. Tyrosinase activity was determined in vitro by the spectrophotometric method. Results: Molecular docking data suggest the feasibility of synthesizing 2-substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one as possible tyrosinase inhibitors. Of particular interest are compounds with hydroxy groups in the radical. Next, pharmacological screening showed that the leading compound is 4g. It is likely that metal–ligand interactions are the main interactions in the active site of tyrosinase because kojic acid, hydroquinone, and lactic acid (reference compounds), as well as compounds with only hydroxy groups in phenyl substituents (4b, 4c, and 4g), have the greatest anti-tyrosinase activity. Conclusions: As a result of molecular docking studies, the feasibility of synthesizing 2-substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one as potential tyrosinase inhibitors was justified. 2-Substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one was obtained using new synthesis conditions. The leading compound is 4g containing a fragment of 2,4-dihydroxybenzene.

26 April 2022 in Chimica Techno Acta
Verified
Journal Article
Open access
PDF file
ACAlexey S. Chiriapkin
Alexey S. Chiriapkin
IKIvan P. Kodonidi
Ivan P. Kodonidi
DPDmitry Pozdnyakov
Dmitry Pozdnyakov
AGAlexander A. Glushko
Alexander A. Glushko
Alzheimer's disease is a chronic neurodegenerative disease, which is characterized mainly by a progressive decrease in intellectual abilities, memory impairment and a change in a person's personality. Unfortunately, there are practically no medicines that act on pathogenesis of Alzheimer's disease. The development of new highly effective medicines for the treatment of this pathology is an actual area of pharmaceutical research. The aim of this work is to search among 2-substituted 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one effective compounds with an anticholinesterase and an antiamyloid activities. As a result, it was found that compounds 4d, 4e and 4f have the high anticholinesterase ability, which in their structure contain residues of hydroxy-methoxyphenyl fragments. Structures 4c, 4g, 4h, 4j, 4k, 4m, 4n and 4p showed slightly less activity, the effect of which did not differ statistically from that of Donepezil. Compounds 4c, 4e, 4k and 4m have the greatest ability to inhibit the formation of the amyloid, comparable to GV-971. It should be noted that the molecular docking data are consistent with the results of the determination of the anticholinesterase activity of the studied compounds obtained in vitro. Thus, the prospects for future studies of these compounds in the possibility of creating a pharmaceutical active substance for the treatment of neurodegenerative diseases have been revealed.

29 May 2021 in Drug development & registration
Verified
Journal Article
Open access
PDF file
ACA. S. Chiriapkin
A. S. Chiriapkin
IKI. P. Kodonidi
I. P. Kodonidi
MLM. V. Larsky
M. V. Larsky
Introduction. Azomethine derivatives of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide are acyclic precursors of biologically active compounds derived from 5,6,7,8-tetrahydro-3H-benzoteopheno[2,3-d]pyrimidine-4-one. Examples of these groups of compounds with different pharmacological properties are given in the literature, but their cytostatic effect is mainly described. These data and the preparative availability allow us to judge the prospects for further study and molecular design in a number of azomethine derivatives of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide. Optimization of methods for the synthesis and analysis of substances of this series and the identification of structure-activity relationship are of considerable interest for medical chemistry and pharmaceutical science. The resulting leading compounds will allow us to further develop laboratory requirements for the synthesis of an active pharmaceutical substance.Aim. To make a predict, optimize the synthesis conditions and develop a method for high performance liquid chromatography (HPLC) analysis of pharmacologically active azomethine derivatives of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide.Materials and methods. The prediction of biological activity was carried out through the web resource PASS Online. The synthesis of the target azomethines was carried out by the interaction of aromatic aldehydes with 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide in an ethanol. The reaction was monitored by thin-layer chromatography (TLC). The determination of related impurities was done by HPLC. The analysis was carried out under the conditions of isocratic elution with a mobile phase of acetonitrile – water (70:30).Results and discussion. The results of the prediction of the biological activity of the constructed structures suggest the manifestation of cytostatic, antitubercular and anti-inflammatory activity characteristic of all target azomethines. The analysis of the reactivity revealed the influence of substituents of aldehydes contained in the aromatic core on the completeness of the condensation reaction. The spectral characteristics clearly confirmed the structure of the products, and the HPLC results showed the purity of the obtained substances, which is more than 95 %.Conclusion. As a result of the conducted studies, the structure of promising azomethine derivatives of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide was justified and the method of their synthesis and analysis by HPLC was optimized. In the future, the results of the research will allow us to identify the leading compounds with the specified pharmacological properties.

15 August 2023 in Bulletin of Science and Practice
Verified
Journal Article
Closed access
ABA. Bidzhieva
A. Bidzhieva
ACA. Chiriapkin
A. Chiriapkin
Various parts of plants have long been widely used for the treatment and prevention of diseases. They are a valuable source of biologically active compounds, especially they are rich in polyphenolic structures. Rutin belongs to the group of some of the most common flavonoids in plant objects. Animal organisms do not have enzyme systems for its synthesis, so it enters the human body only with plant food. Rutin is widely used as a component in herbal medicines, multivitamin preparations, in the cosmetology, food and chemical industries. This article discusses the biological activity of rutin, namely antidiabetic, antioxidant, anti-inflammatory and antitumor activity. The article summarizes the current data on the above-mentioned types of biological activity. It follows from the presented research results that rutin is a promising compound with multi-target activity for the treatment of various diseases. It can serve as a basis for the creation of new highly effective pharmacological molecules based on it.

1 January 2022 in Juvenis scientia
Verified
Journal Article
Open access
PDF file
ACA. S. Chiriapkin
A. S. Chiriapkin
Pyrimidine derivatives represent an extensive class of organic compounds that contain in their structure a six-membered heterocycle with two nitrogen atoms at positions 1 and 3. Substances of this group have a wide range of pharmacological activity, which makes it possible to consider the pyrimidine core as a promising scaffold for the development of new biologically active compounds. The article provides an analysis of the literature data of pyrimidine derivatives used in medical practice. For example, there are substances with antiviral, psychotropic, antimicrobial, antitumor, antifungal, antiparasitic and anabolic activity. Based on the structure-activity relationship of pyrimidine structures of active drugs, as well as other compounds that are considered candidates for the development of new drugs, it is possible to search for and design compounds with the desired types of pharmacological activity. Thus, a systematic analysis of pyrimidine derivatives from a pharmacological point of view can serve as a basis for further search for new highly effective and safe medicines.